awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33440251-24FCF699-9FEA-4198-AA7C-DC59FA705683
Q33440251-24FCF699-9FEA-4198-AA7C-DC59FA705683
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33440251-24FCF699-9FEA-4198-AA7C-DC59FA705683
The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma.
P1476
Q33440251-24FCF699-9FEA-4198-AA7C-DC59FA705683
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33440251-24FCF699-9FEA-4198-AA7C-DC59FA705683
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
78cae4f2d817917b050b48d03d672d44398cf7e1
P1476
The PARP Inhibitor Veliparib C
......
f Activity in B-Cell Lymphoma.
@en